Charité-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2020

  1. Sarcoma treatment in the era of molecular medicine

    EMBO Molecular Medicine, Vol. 12, Núm. 11

2016

  1. Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/TRAIL-Cisplatin combination therapy in cervical cancer

    Genes Chromosomes and Cancer, Vol. 55, Núm. 2, pp. 177-189

2009

  1. Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer

    Genes Chromosomes and Cancer, Vol. 48, Núm. 11, pp. 983-992

2008

  1. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression

    Genes Chromosomes and Cancer, Vol. 47, Núm. 9, pp. 755-765

2007

  1. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes

    Genes Chromosomes and Cancer, Vol. 46, Núm. 4, pp. 373-384

2006

  1. Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression

    Molecular Cancer, Vol. 5